-
Faron Announces First Patient Dosed in BLAZE Investigator-Initiated Trial
First clinical evaluation of bexmarilimab plus nivolumab in patients with anti-PD-1-resistant solid tumors TURKU, FI /
Lifestyle Content
Technology
-
Press Release: Sanofi and Regeneron expand global Alliance with multiple next-generation, long-acting immunology antibodies
-
NIO Inc. Provides September and Third Quarter 2026 Delivery Update
-
National MS Society Launches Campaign to End MS, Declaring for the First Time: Ending MS Is Within Reach
-
From Overseas Range Records to Zero-Carbon Factories: Chery Auto to Showcase Green Technology at 2026 Chery International User Summit
-
California Creates Landmark Dementia Registry as Governor Newsom Signs SB 1047 Into Law
Entertainment
-
Pragmatic123 Expands Customer Support With 24/7 Live Chat
-
Terry Gray Introduces Math Adventures, an Interactive Math Workbook for K–8 Learners
-
Dr. Kimberly Offutt Releases Say Yes: Embracing the Unexpected Journey of Foster Care
-
Stephanie J. Katz Releases My Hyperhidrosis Transformation, a Faith-Based Guide for Living With Hyperhidrosis
-
Top IPTV Service Providers for 2026/2027 (Honest IPTV Subscription Reviews)
Health
-
Edmunds ranks the best SUVs for parents
-
Why more policyholders are exploring what their life insurance is worth beyond surrender value
-
The metro areas with America’s worst commutes aren’t the ones with the worst insurance bills
-
How much square footage a $500K housing budget buys across US metros
-
Survey: Nearly half of Americans are comfortable with AI approving or denying their mortgage
